Key result
Postoperative troponin elevation linked to ~15.5-fold higher 30-day mortality after colorectal surgery.
Why the study?
International guidelines support perioperative troponin monitoring in noncardiac surgery, but regional data on the risk factors and prognostic impact of postoperative troponin elevation after colorectal surgery in a Saudi cohort were limited.
Does postoperative troponin elevation increase the risk of 30-day mortality and stroke in patients undergoing colorectal surgery?
Cohort (n=613)
No
Does postoperative troponin elevation increase the risk of 30-day mortality and stroke in patients undergoing colorectal surgery?
Postoperative troponin elevation following colorectal surgery is an independent predictor of 30-day mortality and stroke, supporting the prognostic value of perioperative troponin monitoring.
Answers are grounded in this paper and cite their sources.
Troponin elevation flags high-risk colorectal surgery patients; supports monitoring but leaves open whether routine surveillance improves outcomes.
Introduction: Colorectal surgery (CRS) is a common major surgical procedure, often performed in patients with significant comorbidities that increase cardiovascular risk. Elevated postoperative troponin levels have been linked to increased mortality in noncardiac surgeries, even when asymptomatic. While international guidelines support perioperative troponin monitoring, regional data are limited. Therefore, this study aimed to investigate the risk factors and prognostic impact of troponin elevation (TE) after CRS in a Saudi cohort.Methodology: This retrospective record review included all patients who underwent CRS at King Abdulaziz University Hospital (Jeddah, Saudi Arabia) between January 2013 and June 2020. It excluded patients who did not undergo an intraperitoneal procedure. Data were collected from electronic medical records, including demographics, preoperative laboratory results, operative details, and postoperative outcomes, particularly troponin levels and complications within 30 days postoperative.Results: A total of 613 patients underwent CRS, of which 17.8% had TE. Patients with TE had significantly higher 30-day mortality (25.7% vs. 2.2%, p < 0.001) and stroke (6.4% vs. 0.8%, p < 0.001) compared to those without TE. TE was associated with older age, lower preoperative hemoglobin and albumin (ALB) levels, renal dysfunction, and higher American Society of Anesthesiologists’ classification. TE was more common among patients who underwent urgent and open surgeries and in those with comorbidities such as hypertension, ischemic heart disease, and cerebrovascular disease. Logistic regression revealed that TE independently predicted 30-day mortality (odds ratio [OR]: 15.49, 95% confidence interval [CI]: 7.42–32.34, p < 0.001) and stroke (OR: 8.58, 95% CI: 2.47–29.85, p < 0.001). TE was also associated with longer hospital stays, increased need for monitored care, and higher transfusion rates.Conclusion: This study found that TE is associated with higher 30-day mortality and stroke risk after CRS, though this does not imply causation. Future research should investigate the outcomes of asymptomatic postoperative TE in patients undergoing CRS.
No takes yet. Share an insight, caveat, or question.
Farsi et al. (2026) conducted a cohort in Patients undergoing colorectal surgery (n=613). Postoperative troponin elevation vs. No postoperative troponin elevation was evaluated on 30-day mortality (OR 15.49, 95% CI 7.42-32.34, p=<0.001). Postoperative troponin elevation after colorectal surgery independently predicted higher 30-day mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: